Related Experiment Video
Updated: Jul 12, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
New and emerging strategies for targeting cancers: Challenges and opportunities (Review)
Sreenivasa R Chinni1,2,3, Arun K Rishi3,4, Kaladhar B Reddy2
1Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
Despite improvements in treatment strategies for cancer patients, the response to treatment by chemotherapy or immunotherapy has benefited a small percentage of cancer patients, depending on tumor histology and other host factors. The mechanism of resistance is poorly understood because cancer cells exhibit extensive plasticity, enabling them to acquire resistance to chemo- and immunotherapy. This review summarizes the current understanding of interactions between chemo- and immunotherapy and their targets, including recent advancements in the regulatory mechanisms that control chemo- and/or immunotherapy response and resistance in cancer. Furthermore, a variety of chemotherapy and/or immunotherapies are discussed, along with recent developments aimed at preventing resistance and relapses following treatment, with a focus on upcoming initiatives to improve the efficacy of chemo- and immunotherapy for cancer patients.
Insights
Cancer treatment resistance to chemotherapy and immunotherapy is poorly understood due to cancer cell plasticity. This review explores mechanisms of resistance and strategies to improve treatment efficacy.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Chemotherapy and immunotherapy offer improved cancer treatment strategies.
- However, only a small percentage of patients respond effectively due to tumor histology and host factors.
- Cancer cell plasticity contributes to resistance against both treatment modalities.
Purpose of the Study:
- To review the current understanding of chemo- and immunotherapy interactions and targets.
- To summarize advancements in regulatory mechanisms controlling treatment response and resistance.
- To discuss strategies for preventing resistance and relapse, enhancing treatment efficacy.
Main Methods:
- Literature review of current research on cancer treatment response and resistance.
- Analysis of regulatory mechanisms in chemo- and immunotherapy.
- Examination of emerging therapeutic strategies and upcoming initiatives.
Main Results:
- Cancer cells exhibit plasticity, leading to acquired resistance to chemotherapy and immunotherapy.
- Understanding regulatory mechanisms is crucial for predicting and overcoming resistance.
- Various chemotherapy and immunotherapy approaches are being developed to combat resistance.
Conclusions:
- Elucidating resistance mechanisms is key to improving patient outcomes.
- Novel strategies are needed to enhance the efficacy of chemotherapy and immunotherapy.
- Future research should focus on overcoming resistance and preventing cancer relapse.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

